Ultomiris’ Shared “Now Approved” Page for Patients and HCPs Jan 10, 2019Jan 8, 2019 Brand: Ultomiris (ravulizumab-cwvz), Injection Parent Company: Alexion Pharmaceuticals Drug Type: Boxed Warning Drug Category: Hematology Campaign: now-approved Targeting: HCPs, Patients, Caregivers Patient Website: https://www.ultomiris.com/ HCP Website: Now Approved Page Now Approved Page (Mobile)